NanoViricides Inc.

AMEX: NNVC · Real-Time Price · USD
1.49
0.02 (1.71%)
At close: Aug 15, 2025, 3:59 PM
1.49
0.00%
After-hours: Aug 15, 2025, 07:35 PM EDT

NanoViricides Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
190.6K 380.56K 569.89K 759.01K 757.29K 755.66K 753.25K 747.53K 746.6K 739.84K 730.3K 723.33K 711.53K 706.12K 528.73K 352.31K 176.14K n/a n/a
Gross Profit
-190.6K -380.56K -569.89K -759.01K -757.29K -755.66K -753.25K -747.53K -746.6K -739.84K -730.3K -723.33K -711.53K -706.12K -528.73K -352.31K -176.14K n/a n/a
Operating Income
-9.87M -9.53M -9.65M -8.52M -9.8M -9.7M -9.35M -8.94M -7.06M -7.04M -7.12M -8.11M -8.4M -8.71M -9.09M -8.74M -8.5M -8.94M -8.28M
Interest Income
140.48K 162.03K 213.46K 271.77K 342.78K 396.79K 402.61K 355.83K 249.45K 141.52K 54.63K 2.26K 5.34K 7.36K 6.48K 9.35K 8.08K 15.32K 14.92K
Pretax Income
-9.73M -9.36M -9.45M -8.29M -9.51M -9.36M -8.99M -8.59M -6.8M -6.89M -7.06M -8.11M -8.4M -8.72M -9.12M -8.82M -8.62M -14.6M -14.2M
Net Income
-9.73M -9.36M -9.45M -8.29M -9.51M -9.25M -8.79M -8.34M -6.55M -6.75M -7.02M -8.11M -8.4M -8.72M -9.12M -8.82M -8.62M -14.6M -14.2M
Selling & General & Admin
4.31M 3.85M 3.37M 2.7M 2.25M 2.36M 2.61M 2.55M 2.41M 2.33M 2.32M 2.33M 2.2M 2.31M 2.45M 2.63M 2.9M 3.67M 3.49M
Research & Development
5.55M 5.49M 5.9M 5.44M 7.17M 7.15M 6.75M 6.39M 4.65M 4.71M 4.8M 5.78M 6.2M 6.41M 6.64M 6.11M 5.6M 5.27M 4.79M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
9.87M 9.34M 9.27M 8.14M 9.42M 9.51M 9.35M 8.94M 7.06M 7.04M 7.12M 8.11M 8.4M 8.71M 9.09M 8.74M 8.5M 8.94M 8.28M
Interest Expense
149.00 149.00 13.31K 49.81K 49.81K 49.81K 36.59K 938.00 938.00 5.73K 8.26K 8.31K 10K 7.72K 42.39K 85.41K 128.32K 170.74K 137.58K
Selling & Marketing Expenses
n/a -189.96K -379.29K -379.29K -379.29K -189.33K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.62M 9.53M 9.65M 8.52M 9.8M 9.7M 9.35M 8.94M 7.06M 7.04M 7.12M 8.11M 8.4M 8.71M 9.09M 8.74M 8.5M 8.94M 8.28M
Income Tax Expense
n/a 4.00 4.00 4.00 4.00 -107.94K -196.8K -248.51K -236.66K -123.93K -32.44K 19.47K 10.69K 7.92K 5.29K 8.16K 6.89K 49.81K 49.81K
Shares Outstanding (Basic)
16.03M 14.57M 13.72M 11.87M 11.78M 11.75M 11.72M 11.7M 11.64M 11.61M 11.59M 11.56M 11.54M 11.53M 11.52M 10.95M 10.95M 10.67M 10.49M
Shares Outstanding (Diluted)
16.03M 14.57M 13.72M 11.87M 11.78M 11.75M 11.72M 11.7M 11.64M 11.61M 11.59M 11.56M 11.54M 11.53M 11.52M 10.95M 10.95M 10.67M 10.49M
EPS (Basic)
-0.71 -0.73 -0.77 -0.71 -0.82 -0.8 -0.76 -0.72 -0.56 -0.58 -0.61 -0.71 -0.75 -0.78 -0.83 -0.82 -0.81 -1.86 -2.14
EPS (Diluted)
-0.71 -0.73 -0.77 -0.71 -0.82 -0.8 -0.76 -0.72 -0.56 -0.58 -0.61 -0.71 -0.75 -0.78 -0.83 -0.82 -0.81 -1.86 -2.14
EBITDA
-9.22M -8.63M -8.71M -7.49M -8.7M -8.55M -8.2M -7.84M -6.05M -6.14M -6.33M -7.38M -7.68M -8M -8.38M -8.03M -7.79M -13.73M -13.36M
EBIT
-7.51M -9.36M -9.44M -8.24M -9.46M -9.31M -8.95M -8.59M -6.8M -6.88M -7.06M -8.1M -8.39M -8.71M -9.08M -8.74M -8.5M -14.43M -14.06M
Depreciation & Amortization
582.1K 772.05K 765.5K 759.01K 757.29K 755.66K 753.25K 747.53K 746.6K 739.84K 730.3K 723.33K 711.53K 706.12K 703.73K 704.54K 703.36K 702.15K 702.07K